Oreola Donini
Senior VP & Chief Scientific OfficerDr. Oreola Donini, Ph.D., has been the Chief Scientific Officer and Senior Vice President at Soligenix, Inc. since December 5, 2014. Dr. Donini served as Vice President of Preclinical Research and Development at Soligenix, Inc. since August 15, 2013 until December 4, 2014. From 2004 to 2013, Dr. Donini worked with Inimex Pharmaceuticals Incorporated (“Inimex”), lastly as Senior Director of Preclinical R&D from 2007-2013. Dr. Donini served as a Program Director at Kinetek Pharmaceuticals Inc. and managed a team which provided molecular modelling, bioinformatics and cheminformatics services. Dr. Donini has broad experience in drug discovery and preclinical development with start-up biotechnology companies and is instrumental in leading early stage development of several novel therapies into the clinic. She served as Vice President of Research and Development at ESSA Pharma Inc from 2012 till 2013. Dr. Donini has received numerous graduate awards for her research on in silico design and computational chemistry. Dr. Donini received her Ph.D. from Queen’s University in Kingston, Ontario and completed post-doctoral studies at the University of California, San Francisco.
Positions
- Company NameSoligenix, Inc.Stock CodeSNGXPositionSenior VP & Chief Scientific OfficerColleagues
- CJChristopher J. SchaberChairman of the Board of Directors, CEO & President
- JLJonathan L. GuarinoSenior VP, CFO & Corporate Secretary
- ATAdam T. RumageSenior VP of Project Management & Regulatory Affairs
- GAGregory Anthony LapointeIndependent Director
- RJRobert J. RubinIndependent Director
- JBJerome Bernard ZeldisIndependent Director
- BPBrian PoligoneChair of Cutaneous T-Cell Lymphoma Medical Advisory Board
